Sensex remains volatile but Midcap outperforms; pharma stocks up

Sun Pharma to acquire Ranbaxy in $4 billion all-stock dealSun Pharma to acquire Ranbaxy in $4 billion all-stock deal

Benchmark indices remained volatile in morning trade, with the Nifty hovering around 9,850 level as investors looked for triggers after digesting Infosys and PSU banks consolidation news.

The 30-share BSE Sensex was up 17.56 points at 31,585.57 and the 50-share NSE Nifty rose 4.20 points to 9,856.70.

The broader markets outperformed benchmarks as the BSE Midcap and Smallcap indices gained 0.3 percent each on positive breadth.

 About 1,113 shares advanced against 807 declining shares on the BSE.

Infosys, Tata Motors, Lupin and Sun Pharma top four contributors to Sensex’ gains but upside is capped by HDFC Group stocks.

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Facebook Twitter YouTube Pinterest Linkedin Google+

You may also like:

Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited' width= Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed' width=
Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed
Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300